However, this might be because the mutation does not inhibit drug-induced activation of p53 function, as seen in HCA7 colorectal cells, or because wild-type p53 in some tumors does not become activated after being exposed to therapeutic drugs, as shown in the NCI-747 colorectal tumor model [143]. This evidence concerns the gene TP53 and colorectal neoplasm.